THERAPEUTIC STRATEGY COMBINING INTRAVENOUS CYCLOPHOSPHAMIDE FOLLOWED BY ORAL MYCOPHENOLATE MOFETIL TO TREAT SEVERE OR WORSENING INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS

被引:0
|
作者
Duchange, Al [1 ]
Mouthon, L. [2 ]
Berezne, A. [2 ]
Morell-Dubois, S. [1 ]
Hatron, P. Y. [1 ]
Guillevin, L. [2 ]
Hachulla, E. [1 ]
Launay, D. [1 ]
机构
[1] Hop Claude Huriez, Ctr Reference Sclerodermie, CHRU, Serv Med Interne, Lille, France
[2] Hop Cochin, Ctr Reference Vasc & Sclerodermie, Serv Med Interne, F-75674 Paris, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S165 / S165
页数:1
相关论文
共 50 条
  • [21] Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
    Tzouvelekis, Argyris
    Galanopoulos, Nikolaos
    Bouros, Evangelos
    Kolios, George
    Zacharis, George
    Ntolios, Paschalis
    Koulelidis, Andreas
    Oikonomou, Anastasia
    Bouros, Demosthenes
    PULMONARY MEDICINE, 2012, 2012
  • [22] Safety and Tolerability of Cyclophosphamide Versus Mycophenolate for Systemic Sclerosis-Related Interstitial Lung Disease
    Volkmann, Elizabeth R.
    Roth, Michael
    Elashoff, Robert
    Clements, Philip J.
    Furst, Daniel E.
    Khanna, Dinesh
    Goldin, Jonathan
    Tashkin, Donald
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [23] MYCOPHENOLATE MOFETIL VERSUS ORAL CYCLOPHOSPHAMIDE IN SCLERODERMA-RELATED INTERSTITIAL LUNG DISEASE: SCLERODERMA LUNG STUDY II
    Khanna, D.
    Roth, M.
    Clements, P.
    Furst, D.
    Tseng, C. -H.
    Elashoff, R.
    Volkmann, E.
    Kafaja, S.
    Goldin, J.
    Tashkin, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 531 - 531
  • [24] Mycophenolate Mofetil Improves Exercise Tolerance in Systemic Sclerosis Patients with Interstitial Lung Disease: A Pilot Study
    Vaiarello, Valentina
    Schiavetto, Stefano
    Foti, Federica
    Gigante, Antonietta
    Iannazzo, Francesco
    Paone, Gregorino
    Palange, Paolo
    Rosato, Edoardo
    RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 1037 - 1044
  • [25] Mycophenolate Mofetil Improves Exercise Tolerance in Systemic Sclerosis Patients with Interstitial Lung Disease: A Pilot Study
    Valentina Vaiarello
    Stefano Schiavetto
    Federica Foti
    Antonietta Gigante
    Francesco Iannazzo
    Gregorino Paone
    Paolo Palange
    Edoardo Rosato
    Rheumatology and Therapy, 2020, 7 : 1037 - 1044
  • [26] Pulse intravenous cyclophosphamide in the treatment of interstitial lung disease in patients with systemic sclerosis.
    Font, J
    Jimenez, S
    Ramos-Casals, M
    Cervera, R
    Trejo, O
    De la Red, G
    Gil, V
    Garcia-Carrasco, M
    Ingelmo, M
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S318 - S318
  • [27] Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease
    George Yiannopoulos
    Vassilios Pastromas
    Ioannis Antonopoulos
    George Katsiberis
    George Kalliolias
    Stamatis-Nick Liossis
    Andrew P. Andonopoulos
    Rheumatology International, 2007, 27 : 357 - 361
  • [28] Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease
    Yiannopoulos, George
    Pastromas, Vassilios
    Antonopoulos, Ioannis
    Katsiberis, George
    Kalliolias, George
    Liossis, Stamatis-Nick
    Andonopoulos, Andrew P.
    RHEUMATOLOGY INTERNATIONAL, 2007, 27 (04) : 357 - 361
  • [29] COST EFFECTIVENESS OF MOFETIL MYCOPHENOLATE COMPARED WITH CYCLOPHOSPHAMIDE FOR THE TREATMENT OF SYSTEMIC SCLEROSIS IN PATIENTS WITH DIFFUSE INTERSTITIAL PULMONARY DISEASE IN COLOMBIA
    Paola Saavedra, Ginna
    Bello Gualtero, Juan Manuel
    Quitian Reyes, Hoover
    Buitrago-Gutierrez, Giancarlo
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S8 - S8
  • [30] Interstitial lung disease associated with systemic sclerosis -: What is the evidence for efficacy of cyclophosphamide?
    Berezne, Alice
    Valeyre, Dominique
    Ranque, Brigitte
    Guillevina, Loic
    Mouthon, Luc
    AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH, 2007, 1110 : 271 - 284